|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A phaseⅢ,randomized,placebo-controlled study of belimumab,a monoclonal antibodythat inhibits B lymphocyte stimulator,in patients withsystemic lupus erythematosus显示文摘 | Furie R Petri M Zamani O | 2011 | Arthritis Rheum2011，63，12： | 1 |
| 2 | Association between tPA therapy and raided early matrix metalloproteinase-9 in acute stroke 显示文摘 | Ning M Furie KL Koroshetz WJ | 2006 | Neurology2006，66，10： | 1 |
| 3 | Continuouscoolingtransformationdiagramsandpropertiesofmicro-alloyedTRIPsteels显示文摘 | Zhang M LiL FuRY etal | 2006 | MaterialsScienceandEngineeringA2006，438，： | 1 |
| 4 | Associa- tion between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke显示文摘 | Ning M Furie KL Koroshets WJ | 2006 | Neurology2006，66，10： | 1 |
| 5 | A phaseⅢ,randomized,placebo-controlled study of belimumab,a monoclonal antibody that inhibits B lymphocyte stimulator,in patients with systemic lupus erythematosus显示文摘 | Furie R Petri M Zamani O | 2011 | Arthritis Rheum2011，63，12： | 1 |
| 6 | Novel lipogenic enzyme ELOVL7 is in- volved in prostate cancer growth through saturated long-chain fatty acid metabolism显示文摘 | Tamura K Makino A Hullin-Matsuda F Kobayashi T Furi hata M Chung S | 2009 | Cancer Res2009，69，： | 1 |
| 7 | Monocytes use either CD11b/CDI8 or VLA4 to migrate across human endothelium in vitro显示文摘 | MEERCHAERT J FURIE M B | 1994 | J Immunol1994，152，2： | 1 |
| 8 | Optical and electri cal spin injection and spin transport in hybrid Fe/GaAs devices 显示文摘 | Crooker S A Furis M Lou X | 2007 | J Appl Phys2007，101，08： | 1 |
| 9 | Trp2313-His2315 of factor Ⅷ C2 domain is involved in membrane binding:structure of a complex between the C2 domain and an inhibitor of membrane binding显示文摘 | Liu Z Lin L Yuan C Nicolaes G A Chen L Meehan E J Furie B Huang M | | 0，，： | 1 |
| 10 | Randomised prospective trialcomparing the native prothrombin antigen with the prothrombintime for monitoring oral anticoagulant therapy显示文摘 | Furie B Biuguid CF Jacobs M | 1990 | Blood1990，75，2： | 1 |
| 11 | A phase Ⅲ, ran domized, placebo-controlled study of belimumah, a mono clonal antibody that inhibits B lymphocyte stimulator, in pa tients with systemic lupus erythematosus显示文摘 | FURIE R PETRI M ZAMANI O | 2011 | Arthritis and Rheumatism2011，63，12： | 1 |
| 12 | A phase Ⅲ,randomized,placebo-controlled study of belimumab,a monoclonal antibody that inhibits B lymphocyte stimulator,in patients with systemic lupus erythematosus显示文摘 | Furie R Petri M Zamani O | 2011 | Arthritis Rheum2011，63，12： | 1 |
| 13 | Monoclonal antibodies to leukocyte in-tergrins CD11a/CD18 and CD11b/CD18 or inter cellular adhesion molecule-1inhibit chemoattractant-stimulated neutrophil transendothelial migration invitro显示文摘 | Tancinco M Smith C W | 1991 | Blood1991，78，20： | 1 |
| 14 | Emerging Developments in CMP for Semiconductor Planarization-part 2显示文摘 | Fury M A | 1995 | Solid State Technol1995，38，7： | 1 |
| 15 | A phase III, random- ized, placebo-controlled study of belimumab, a mono- clonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus 显示文摘 | Furie R Petri M Zamani O | 2011 | Arthritis Rheumatism2011，63，12： | 1 |
| 16 | Fibromascular dysplasia of the atreris- es of the head and neck: imaging findimg显示文摘 | Furie D M Tien R D | 1994 | AJR1994，162，2： | 1 |
| 17 | A phase I trial of intermittcnt high-dose gefitinib and fixed-dose docetaxel in patients with ad vanced solid tumors 显示文摘 | Fury M G Solit D B Su Y B | 2007 | Cancer Chemother Pharmacol2007，59，4： | 1 |
| 18 | Emerging developments in CMP for semiconductor planarization part 2 显示文摘 | Fury M A | 1995 | Solid State Technology1995，38，7： | 1 |
| 19 | Chemical analysis of used three-way catalyst by total reflection X-ray flourescence显示文摘 | Fernández-Ruiz FurióM CabelloGalist F | 2001 | Analytical Chemitry2001，74，21： | 1 |
| 20 | The early days of CMP显示文摘 | FURY M A | 1997 | Solid State Technol1997，40，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员